Posts in Bayh-Dole


Academic Patent Licensing Helps Drive the U.S. Economy

What's even more impressive is the impacts on gross industry output and GDP are up 14% while  the number of U.S. jobs supported rose 12% since the previous …
By Joseph Allen
7 days ago 8

Want to Revive the Economy? Restore the Patent System!

The old arguments that patents inhibit innovation, and non-exclusivity with compulsory licensing leads to a brave new world are now in vogue. We've stood at this fork …
By Joseph Allen
2 months ago 17

Early Stage Innovation’s Chance to Save Itself

Universities in particular must explain to their congressional delegations why R&D must continue to be funded and why its Bayh-Dole based commercialization bridge must be protected …
By Chris Gallagher
4 months ago 0

The National Cancer Institute Didn’t Deserve This Treatment From the New York Times

While those in the military are often thanked for their service, let's also thank researchers like Dr. Rosenberg and his colleagues who spend their lives trying to …
By Joseph Allen
6 months ago 2

Advice for the Trump Administration and New Congress: Protect Bayh-Dole and Restore the Patent System

Bayh-Dole is running on autopilot without Executive branch oversight and U.S. patents are no longer the world's gold standard. Without a course correction, we could be …
By Joseph Allen
7 months ago 3

Commercialization of University Research Threatened by Proposed State Legislation 

EFF’s Reclaim Invention Act, Draft Model Statute may seem an odd approach to folks in DC but when lined up with a state-level lobby of IP-uninformed …
By Chris Gallagher
7 months ago 4

Make American Innovation Great Again

It's a fundamental principal of economics that the secure ownership of personal property is essential for prosperity. Walk through any public park and see how seldomly people …
By Joseph Allen
8 months ago 6

Winning the Drug Development Debate

We create two new companies around academic inventions every day of the year. The critical role such companies play in drug development is clear. The successful integration …
By Joseph Allen
8 months ago 0

Property Rights Key to Bayh-Dole Act’s Success

The focus of the political advocates pushing march-in may be lower drug costs. But the long-term costs of ripping apart IP rights are far higher and more …
By James Edwards
11 months ago 5

NIH Director Collins Stands Up to the March in Mob

The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to …
By Joseph Allen
1 year ago 0

UN Access to Medicines Panel Undermines Bayh-Dole 

We cannot know what biological killer will next emerge, when it will be born and where globalization’s winds will take it. But we do know that …
By Chris Gallagher
1 year ago 1

When Government Tried March In Rights To Control Health Care Costs

As we await the decision from the National Institutes of Health (NIH) on the petition backed by Senator Bernie Sanders and others urging that the march in …
By Joseph Allen
1 year ago 10

NIH Pressured to Misuse Bayh-Dole to Control Drug Prices

Secretary Burwell and Director Collins are facing formidable pressure to reinterpret the Bayh-Dole Act for the compulsory licensing of costly drugs arising from federally supported research. And …
By Joseph Allen
1 year ago 6

Winning the Patent Policy Wars

We're in the business of transforming early stage, publicly funded research into useful products. The odds against success are long as commercialization requires years of hard work, …
By Joseph Allen
1 year ago 2

Senate Small Business Committee hearing focuses protecting rights of patent owners

Committee chairman Senator David Vitter (R-LA) began the hearing by speaking about the importance of a strong patent system to small businesses all over America, as well …
By Steve Brachmann
1 year ago 5